Jeeva's virtual control room empowers biopharma and medical device sponsors to conduct modern clinical trials from start to finish with real-time monitoring, driving efficiency, reducing risks, and lowering costs—all with a single login and subscription. The platform significantly alleviates logistical challenges for both participants and study teams by offering features like bi-directional communication, eligibility screening, scheduling, EDC, eCOA, TeleVisits, and remote, touchless electronic informed consent.

Powered by AI, the Jeeva platform automates and centralizes visit schedules and protocol configuration, which seamlessly integrates with its various modules. These include eConsent, ePRO/eCOA/EDC, TeleVisits/VideoVisits, adverse event capture with MedDRA coding, and a patient engagement portal that supports SMS, email, audio, and video communications, reminders, and notifications.

Jeeva’s mission is deeply personal. After losing a child to a rare disease and a brother to a chronic illness, Dr. Harsha Rajasimha channeled his postdoctoral expertise at NIH and FDA to speed up the development of therapies for both rare and common diseases. Recognizing that technology was not the barrier, Dr. Rajasimha focused on patient-centered design informed by stakeholder needs and regulatory compliance to create Jeeva’s continually evolving digital platform. By digitizing and automating over 70% of manual, repetitive tasks, Jeeva lightens the logistical load for patients and study teams, accelerating clinical trial timelines by over threefold. Based in Virginia, Jeeva’s modular SaaS platform is fully scalable, promoting diverse patient enrollment, engagement, and evidence generation through any browser-enabled mobile device.